RxDoctor Payments Data

Aamir Ehsan, MD

Anatomic Pathology & Clinical Pathology · San Antonio, TXNPI 1467569459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Blueprint Medicines Corporation at 36.6% of the total. That places this record below the midpoint for anatomic pathology & clinical pathology clinicians in TX, where the typical reported total is $104.

$84in general payments, 2019–2025

Across 4 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$31
  • Adaptive Biotechnologies Corporation$20
  • Novartis$19
  • Genentech USA, Inc.$15
$600,804in research payments, 2019–2025

Across 68 payments — averaging $8835.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BD$332K
  • Ventana Medical Systems, Inc.$269K

What the payments were for

  • Food & beverage$84100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$84 in reported general payments places this provider in the 45th percentile of 736 anatomic pathology & clinical pathology providers in Texas.

See all anatomic pathology & clinical pathology providers in Texas

Medicare billing

Part B allowed, 2024
$992,282
Medicare patients
2,378
Services billed
14,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →